Literature DB >> 15947493

Association between impaired insulin sensitivity and stroke.

Dawn M Bravata1, Carolyn K Wells, Walter N Kernan, John Concato, Lawrence M Brass, Barbara I Gulanski.   

Abstract

BACKGROUND: Prior research has indicated an association between insulin resistance and stroke; we sought to determine if this association persists after adjusting for stroke risk factors, including glycemic control.
METHODS: We used data from the Third National Health and Nutrition Survey (1988-1994), including participants aged > or =40 years. We assessed insulin sensitivity using the homeostasis model assessment (HOMA): HOMA = (FPGSI x FPI)/22.5, where FPGSI refers to fasting plasma glucose (mmol/l) and FPI refers to fasting plasma insulin (microU/l). Increasing HOMA indicates decreasing insulin sensitivity. We used glycosylated hemoglobin (HbA1c) to measure glycemic control. Multivariable logistic regression analysis was used to identify factors that were independently associated with stroke.
RESULTS: Among 3,844 participants, 168 (4%) reported a stroke history. Participants with stroke had lower insulin sensitivity than participants without stroke: HOMA mean +/- standard deviation, 4.0 +/- 4.0 vs. 3.3 +/- 3.0; p = 0.022. HOMA was independently associated with stroke (odds ratio 1.06, 95% CI: 1.01-1.12; adjusted for age, hypertension, myocardial infarction, claudication, activity, and HbA1c). The strength of the association between HOMA and stroke was similar to the association between claudication and stroke (index R(2): 0.0032 vs. 0.0036).
CONCLUSIONS: Impaired insulin sensitivity is independently associated with stroke, even after adjustment for glycemic control. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947493     DOI: 10.1159/000086286

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  9 in total

1.  Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.

Authors:  Bhumsoo Kim; Kelli A Sullivan; Carey Backus; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2011-03-08       Impact factor: 8.401

2.  Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.

Authors:  Viktória Havasi; Zoltán Szolnoki; Gábor Talián; Judit Bene; Katalin Komlósi; Anita Maász; Ferenc Somogyvári; András Kondacs; Mihály Szabó; Lajos Fodor; Anita Bodor; Béla Melegh
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.

Authors:  Keita Mayanagi; Prasad V Katakam; Tamas Gáspár; Ferenc Domoki; David W Busija
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-30       Impact factor: 6.200

4.  Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  George Howard; Lynne E Wagenknecht; Walter N Kernan; Mary Cushman; Evan L Thacker; Suzanne E Judd; Virginia J Howard; Brett M Kissela
Journal:  Stroke       Date:  2014-06-26       Impact factor: 7.914

5.  Insulin/PI3K signaling protects dentate neurons from oxygen-glucose deprivation in organotypic slice cultures.

Authors:  Xiaolu Sun; Hang Yao; Robert M Douglas; Xiang Q Gu; Juan Wang; Gabriel G Haddad
Journal:  J Neurochem       Date:  2009-10-26       Impact factor: 5.372

Review 6.  Diabetes mellitus, insulin resistance, hyperglycemia, and stroke.

Authors:  Karen Furie; Silvio E Inzucchi
Journal:  Curr Neurol Neurosci Rep       Date:  2008-01       Impact factor: 5.081

7.  Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.

Authors:  Hannah Gardener; Milita Crisby; Charlotte Sjoberg; Barry Hudson; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Metab Syndr Relat Disord       Date:  2012-11-05       Impact factor: 1.894

8.  Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population.

Authors:  Zhi Du; Liying Xing; Min Lin; Yingxian Sun
Journal:  BMC Cardiovasc Disord       Date:  2020-11-12       Impact factor: 2.298

Review 9.  Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.

Authors:  Jennifer Wittwer; David Bradley
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.